Atomistry » Magnesium » PDB 7thj-7to2 » 7tix
Atomistry »
  Magnesium »
    PDB 7thj-7to2 »
      7tix »

Magnesium in PDB 7tix: Crystal Structure of Sars-Cov-2 3CL in Complex with Inhibitor EB56

Enzymatic activity of Crystal Structure of Sars-Cov-2 3CL in Complex with Inhibitor EB56

All present enzymatic activity of Crystal Structure of Sars-Cov-2 3CL in Complex with Inhibitor EB56:
3.4.22.69;

Protein crystallography data

The structure of Crystal Structure of Sars-Cov-2 3CL in Complex with Inhibitor EB56, PDB code: 7tix was solved by F.Forouhar, H.Liu, S.Iketani, A.Zack, N.Khanizeman, E.Bednarova, B.Fowler, S.J.Hong, H.Mohri, M.S.Nair, Y.Huang, N.E.S.Tay, S.Lee, C.Karan, S.J.Resnick, C.Quinn, W.Li, H.Shion, C.Jurtschenko, M.A.Lauber, T.Mcdonald, M.E.Stokes, B.Hurst, T.Rovis, A.Chavez, D.D.Ho, B.R.Stockwell, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 45.07 / 2.00
Space group C 1 2 1
Cell size a, b, c (Å), α, β, γ (°) 96.729, 81.462, 54.566, 90, 116.62, 90
R / Rfree (%) 17.2 / 21.5

Magnesium Binding Sites:

The binding sites of Magnesium atom in the Crystal Structure of Sars-Cov-2 3CL in Complex with Inhibitor EB56 (pdb code 7tix). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total only one binding site of Magnesium was determined in the Crystal Structure of Sars-Cov-2 3CL in Complex with Inhibitor EB56, PDB code: 7tix:

Magnesium binding site 1 out of 1 in 7tix

Go back to Magnesium Binding Sites List in 7tix
Magnesium binding site 1 out of 1 in the Crystal Structure of Sars-Cov-2 3CL in Complex with Inhibitor EB56


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of Crystal Structure of Sars-Cov-2 3CL in Complex with Inhibitor EB56 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Mg402

b:64.2
occ:1.00
OD1 A:ASP263 2.2 81.1 1.0
O A:HOH502 2.3 60.1 1.0
OD1 A:ASN221 2.4 52.6 1.0
O A:PHE223 2.6 70.2 1.0
O A:ASN221 2.7 46.8 1.0
O A:ASP263 2.7 41.5 1.0
CG A:ASP263 3.3 77.4 1.0
CG A:ASN221 3.4 54.9 1.0
C A:ASN221 3.5 50.1 1.0
C A:ASP263 3.6 47.1 1.0
OG A:SER267 3.6 55.2 1.0
C A:PHE223 3.7 68.1 1.0
N A:ASN221 3.8 54.9 1.0
N A:PHE223 3.9 67.9 1.0
CA A:ASP263 4.0 56.8 1.0
CB A:ALA266 4.1 46.0 1.0
CA A:ASN221 4.1 51.8 1.0
OD2 A:ASP263 4.1 86.0 1.0
N A:SER267 4.1 39.9 1.0
ND2 A:ASN221 4.2 58.8 1.0
CB A:ASP263 4.2 65.6 1.0
C A:ARG222 4.3 72.2 1.0
CA A:PHE223 4.3 65.5 1.0
CB A:ASN221 4.4 53.4 1.0
N A:ARG222 4.4 56.6 1.0
C A:ALA266 4.5 47.5 1.0
N A:MET264 4.6 43.4 1.0
CB A:SER267 4.6 48.0 1.0
CA A:ARG222 4.7 65.7 1.0
CA A:ALA266 4.7 46.2 1.0
O A:ARG222 4.8 79.8 1.0
CA A:SER267 4.8 44.4 1.0
N A:THR224 4.8 64.3 1.0
CB A:PHE223 5.0 68.3 1.0
N A:ALA266 5.0 48.0 1.0

Reference:

H.Liu, S.Iketani, A.Zask, N.Khanizeman, E.Bednarova, F.Forouhar, B.Fowler, S.J.Hong, H.Mohri, M.S.Nair, Y.Huang, N.E.S.Tay, S.Lee, C.Karan, S.J.Resnick, C.Quinn, W.Li, H.Shion, X.Xia, J.D.Daniels, M.Bartolo-Cruz, M.Farina, P.Rajbhandari, C.Jurtschenko, M.A.Lauber, T.Mcdonald, M.E.Stokes, B.L.Hurst, T.Rovis, A.Chavez, D.D.Ho, B.R.Stockwell. Development of Optimized Drug-Like Small Molecule Inhibitors of the Sars-Cov-2 3CL Protease For Treatment of Covid-19. Nat Commun V. 13 1891 2022.
ISSN: ESSN 2041-1723
PubMed: 35393402
DOI: 10.1038/S41467-022-29413-2
Page generated: Thu Oct 3 09:18:28 2024

Last articles

Mg in 8A6V
Mg in 8A6U
Mg in 8A4D
Mg in 8A6H
Mg in 8A29
Mg in 8A6F
Mg in 8A68
Mg in 8A5K
Mg in 8A65
Mg in 8A62
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy